IRCT20230724058910N1尚未招募4 期
To Study the effect of Empagliflozin on the cardiovascular biomarkers Galectin-3 and sST-2 in type 2 diabetic patients myocardial infarction with requiring primary angioplasty
适应症
试验速览
- 阶段
- 4 期
- 状态
- 尚未招募
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- no limit 至 no limit（—）
- 性别
- All
入选标准
- •Type 2 diabetic patients (Hb A1C: 6.5-8)
- •Diabetes treated with oral agents
- •Typical chest pain during the 12 hours before presentation lasting more than 30 minutes
- •ST- segment elevation above 0.1 mV in two leads or more in ECG
排除标准
- •Cardiogenic shock
- •Diabetic ketoacidosis
- •History of CABG
- •Type 1 diabetic patients
- •Severe liver failure
- •End stages cancer or history of any cancer
- •History of severe allergy to empagliflozin or its formulation components
- •Severe renal failure (eGFR <30 mL/minute/1.73 m2), end-stage renal disease (ESRD), or dialysis
- •Hypovolemia
- •Any inflammatory disease under treatment
- •Advanced heart failure
- •Hypoglycemia
研究者
相似试验
尚未招募
2 期
Efficacy of Empagliflozin on cardiac function in non- diabetic patients after primary percutaneous angioplasty on left anterior descending coronary arteryacute myocardial infarction.121-09IRCT20200727048226N1Tehran University of Medical Sciences88
进行中（未招募）
1 期
Impact of Empagliflozin on heart in patients with myocardial infarctioMyocardial infarctionEUCTR2016-004591-22-ATMedical University of Graz/Department of Internal Medicine/Division of Endocrinology and Diabetology476
进行中（未招募）
1 期
Effect of Empagliflozin and Semaglutide on the Cardiovascular system and Kidneys in patients with type 2 diabetes – A randomized TrialMedDRA version: 20.1Level: LLTClassification code 10045242Term: Type II diabetes mellitusSystem Organ Class: 100000004861Type 2 Diabetes MellitusEUCTR2019-000781-38-DKAarhus University Hospital120
尚未招募
3 期
Effect of Empagliflozin on clinical and echocardiographic parameters in patient with reduced LVEF heart failureHeart failureIRCT20210809052117N1Shahid Beheshti University of Medical Sciences44
Unknown
4 期
Effects of Empagliflozin on Cardiac Structure in Patients With Type 2 DiabetesDiabetesCardiovascular DiseaseNCT02998970Unity Health Toronto97